Immediate Impact
73 standout
Citing Papers
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options
2024 Standout
Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
2023 Standout
Works of Patrick Basu being referenced
Sofosbuvir and Ledipasvir Versus Sofosbuvir and Simeprevir Combination Therapy in the Management of Acute Hepatitis C: A Randomized Open Label Prospective Clinical Pilot Study. SLAM C Study, Interim Data
2015
Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Patrick Basu | 155 | 95 | 136 | 56 | 349 | |
| Niraj James Shah | 137 | 85 | 116 | 56 | 314 | |
| Mohammad Reza Ghadir | 167 | 126 | 120 | 49 | 393 | |
| Tajana Filipec Kanižaj | 188 | 131 | 164 | 44 | 357 | |
| Eugen Dumitru | 137 | 35 | 140 | 58 | 408 | |
| Şerif Yılmaz | 117 | 119 | 142 | 28 | 341 | |
| Desai Hg | 78 | 71 | 188 | 64 | 347 | |
| Amr Shaaban Hanafy | 139 | 114 | 99 | 43 | 312 | |
| Lee Sd | 142 | 131 | 132 | 53 | 353 | |
| Rajesh Sharma | 61 | 36 | 148 | 39 | 366 | |
| Girish Kumar Pati | 174 | 90 | 76 | 38 | 380 |
All Works
Loading papers...